Abstract The protein nucleobindin 1 (NUCB1; also known as CALNUC or Nuc) contains an intriguing combination of DNA-and calcium-binding motifs, a trait that it shares with the protein nucleobindin 2 (NUCB2; also known as nesfatin). NUCB2 has been implicated in several aspects of metabolic control and has been identified in a number of endocrine organs. No such comprehensive mapping of NUCB1 has been presented. We have explored the expression and distribution of NUCB1 in tissues and cells of the mouse endocrine system, with particular focus on the endocrine pancreas. Using reverse transcription plus the polymerase chain reaction (RT-PCR) and Western blot, we demonstrate that NUCB1 is present in the endocrine islets of Langerhans but absent from the exocrine acinar cells. Immunofluorescence studies have revealed that all islet cell types contain NUCB1, including the NUCB2-expressing beta cells. RT-PCR, Western blot and immunofluorescence have shown that NUCB1 is expressed in the pituitary, thyroid, parathyroid, gastrointestinal tract, adrenals and gonads. However, within these tissues, NUCB1 expression is not ubiquitous. For example, in the testis, NUCB1 occurs in the seminiferous tubules but not in the Leydig-cell-containing interstitial tissue. Similarly, the lamina propria of the duodenum lacks NUCB1, despite its presence in enterocytes. Where present, NUCB1 consistently appears to be associated with the Golgi apparatus. Thus, NUCB1 is broadly, but not ubiquitously, expressed in cells of the mouse endocrine system. Together with its location in the Golgi apparatus and its putative Ca 2+ -binding ability, this distribution suggests a role for NUCB1 in Ca 2+ handling/sensing in secretory cells.
Introduction
The capacity to sense and respond to changes in intracellular calcium is important for all cell types and is of particular interest in cells with the ability to secrete signalling molecules. These functions involve calcium-binding proteins (CaBPs), a large and diverse group of proteins found in most, if not all, tissues (Yanez et al. 2012) . Nucleobindin 1 (NUCB1; also known as CALNUC or Nuc) has been proposed to contain both calcium-and DNA-binding motifs, including two EFhands, a basic amino-acid-rich region and a leucine zipper. Originally described as a 55-kDa multi-domain protein in a B lymphocyte cell line (Miura et al. 1992) , NUCB1 was later identified as a 63-kDa protein in bone osteoid (Wendel et al. 1995) . NUCB1 has been reported in the Golgi apparatus (Kawano et al. 2000; Lin et al. 1998 ) but evidence has also been presented for its presence in the nucleus (Wang et al. 1994 ) and its secretion from cells (Lavoie et al. 2002) . NUCB1 is highly conserved, among both non-mammals and mammals, with the expression of two isoforms having been reported in the latter (Kanuru et al. 2009 ).
Another member of the nucleobindin family, NUCB2, which is also known as NEFA (for DNA binding, EF hand, acidic region) or nesfatin (for NEFA/NUCB2-encoded satietyand fat-influencing protein) (Barnikol-Watanabe et al. 1994; Oh et al. 2006) , has received considerable attention because of data implicating it in the regulation of food (Oh et al. 2006; Stengel et al. 2011 ) and water (Yosten et al. 2012 ) intake, adiposity (Chen et al. 2013; Tagaya et al. 2012) , insulin secretion (Nakata et al. 2011; Riva et al. 2011) , blood glucose homeostasis (Foo et al. 2010) , sleep (Vas et al. 2013 ) and puberty onset (Garcia-Galiano et al. 2010 , 2012 . NUCB2, which shares 60 % sequence homology with NUCB1 in the mouse genome, including conservation of the DNA-and calcium-binding motifs, is expressed in the hypothalamus (Foo et al. 2008; Oh et al. 2006) , pituitary (Foo et al. 2008; Stengel et al. 2009 ), pancreas (Foo et al. 2010; Gonzalez et al. 2009; Stengel et al. 2009 ), gastrointestinal tract (Stengel et al. 2009; Zhang et al. 2010 ) and testes (Stengel et al. 2009 ).
In contrast to NUCB2, relatively little is known about the function of NUCB1. One step towards such an understanding is to determine its distribution at the tissue, cellular and subcellular levels.
The endocrine system, whose primary function is to produce and secrete hormones upon signalling mediated by calcium influx (Dolensek et al. 2011; Sudhof 2012) , is of particular interest in this regard. Indeed, perturbation of the function of some CaBPs in pancreatic beta cells, such as calbindin or calmodulin, can enhance (Sooy et al. 1999) or impair (Krausz et al. 1980) , respectively, the insulin-secreting capability of the cells. With this in mind, the expression and distribution of NUCB1 has been explored in tissues and cells of the mouse endocrine system, with particular focus on the pancreas as a means of identifying the cell types in which it is found and, subsequently, of shedding light on the possible function of NUCB1.
Materials and methods

Animals
C57BL/6 virgin female and male mice inbred in the animal core facility at Karolinska Hospital (isolated islet experiments only) and from Charles River (Cologne, Germany) were used. The mice were housed in a temperature-controlled environment under 12 h light/12 h dark conditions (lights on at 0600 hours), with free access to tap water and standard rodent chow up to the time of sacrifice. All experiments in this study were performed in accordance with the European Communities Council Directive of 24 November 1986 (86/609/EEC) and were approved by the local ethics committee (Stockholms Norra Djurförsöksetiska Nämnd). All efforts were made to minimise the number and suffering of animals used.
Isolation of pancreatic islets
Mice were killed by cervical dislocation and the pancreas was injected with 3 ml collagenase solution consisting of 1 mg/ml collagenase A (Roche Diagnostics, Mannheim, Germany) in Hank's balanced salt solution (HBSS) via the common bile duct. The pancreas was then removed and incubated in collagenase solution at 37°C for 12 min before being washed and further dissociated by using an 18G needle in HBSS. The islets were handpicked and cultured for 2 h in RPMI-1640 medium (Gibco, Life Technologies, Carlsbad, Calif., USA), supplemented with 10 % fetal calf serum, 200 mM Lglutamine and 500 U penicillin and streptomycin, at 37°C, under 5 % CO 2 and 90 % relative humidity, before being stored at −80°C in phosphate-buffered saline (PBS) until further processing.
Reverse transcription plus polymerase chain reaction C57BL/6 mice (Charles River) aged 7-10 weeks were deeply anaesthetised with an intraperitoneal (i.p.) injection of 0.35 ml sodium pentobarbital (12 mg/ml) and then decapitated. Pituitaries, adrenals, ovaries and testis, and segments from the pancreas, stomach (major curvature), duodenum, jejunum and colon were rapidly dissected out, snap-frozen on dry-ice and stored at −80°C until further processing. Total RNA isolation from the tissues was performed by using the RNeasy mini kit (Qiagen, Venlo, Netherlands), followed by cDNA transcription with SuperScript II Reverse Transcriptase (Invitrogen, Life Technologies, Carlsbad, Calif., USA). NUCB1 cDNA was amplified by the polymerase chain reaction (PCR) with the primers 5′-CTG CTC AAG GCC AAG ATG GA -3′ and 5′-CCT TGA GCA TCT CGT AGC GT -3′ (Eurofins MWG Operon, Ebersberg, Germany). The amplified DNA was separated by electrophoresis in a 1.5 % agarose gel and detected by using standard procedures.
DNA cloning
Full-length sequences of the NUCB1 gene were obtained by PCR amplification of mouse pancreatic islet cDNA by using Phusion High-Fidelity DNA Polymerase (Thermo Scientific, Waltham, Mass., USA) and primers specific for NUCB1 (5′-ATG CCT ACC TCG GTG CCC CG -3′ and 5′-TTATAA ATG CTG GGA ATC CAG C -3′; Eurofins MWG Operon). The amplified sequences were subsequently purified and subcloned into the vector pENTR/D (Invitrogen). All plasmid constructs were confirmed to contain NUCB1-encoding sequences by restriction mapping and DNA sequencing.
Western blot
Tissue samples were collected and frozen by the same method as described for reverse transcription plus PCR (RT-PCR). Samples were thawed on ice and homogenised by using a TissueRuptor (Qiagen) in 1 % SDS containing protease inhibitor cocktail (Sigma, St. Louis, Mo., USA). The protein content of the samples was determined by using a bicinchoninic acid (BCA) test kit (Thermo Scientific). Samples containing 30 μg protein were loaded onto 4-12 % gradient polyacrylamide gels (Invitrogen) and separated by SDS-polyacrylamide gel electrophoresis before transfer onto a polyvinylidene difluoride (PVDF) membrane (Millipore, Billerica, Mass., USA). Membranes were immunoblotted for NUCB1, subsequently labelled with fluorescent secondary antibody (see Table 1 ) and imaged by using an Odyssey infrared detection system (LI-COR, Lincoln, Neb., USA).
Immunofluorescence C57BL/6 mice (Charles River) aged 7-10 weeks were deeply anaesthetised with an i.p. injection of 0.35 ml sodium pentobarbital (12 mg/ml) and were then perfused via the ascending aorta with 10 ml Ca 2+ -free Tyrode's solution containing 0.2 % heparin (37°C), followed by 10 ml Lana's fixative (4 % paraformaldehyde and 0.4 % picric acid in 0.16 M phosphate buffer, 37°C) and then 50 ml ice-cold Lana's fixative. Pituitaries, thyroids (with parathyroids attached), adrenals, ovaries and testis and segments from pancreas, stomach (major curvature), duodenum, jejunum and colon were rapidly dissected out and immersed in ice-cold Lana's fix for 90 min. The tissues were subsequently stored in 0.1 M Sörensen's phosphate buffer (pH 7.4) containing 20 % sucrose, 0.02 % bacitracin and 0.01 % sodium azide for 3 days, before being frozen with CO 2 . The tissues were sectioned on a cryostat (Microm, Walldorf, Germany) at a thickness of 14 μm, thawmounted onto gelatin-coated or Superfrost Plus (Thermo Scientific) slides and then stored at −20°C. For conventional indirect immunofluorescence staining, the air-dried slides were washed in 0.01 M PBS for 30 min before incubation with primary antisera (see Table 1 for full details of antisera used) diluted in PBS containing 0.3 % Triton X-100 for 16 h at 4°C. The slides were then washed for 30 min in PBS followed by a 1-h incubation with secondary antisera. The slides were finally washed for a further 30 min in PBS before being mounted with anti-fade agent (2.5 % DABCO; Sigma) in glycerol. Some slides were incubated with the nuclear marker 4',6-diamidino-2-phenylindole (DAPI; Invitrogen) diluted 1:10,000 in PBS for 5 min before the final wash in PBS. In instances in which double-staining was performed by using two primary antibodies raised in the same species, the Tyramide Signal Amplification (TSA)-Plus protocol (Perkin Elmer, Waltham, Mass., USA) was employed. Slides were incubated in PBS for 15 min prior to treatment with 0.03 % hydrogen peroxide in methanol for 15 min to quench endogenous peroxidase activity and then washed for a further 30 min in PBS before incubation with the primary antisera (as above). Subsequently, slides were washed in TNT buffer (0.1 M TRIS, 0.15 M NaCl and 0.05 % Tween 20) for 30 min and incubated for a further 30 min with TNB blocking reagent (Perkin Elmer). Following this, the slides were incubated for 1 h with horseradish peroxidase (HRP)-conjugated secondary antibody diluted in TNB. Slides were washed for 30 min in TNT before incubation with tyramideconjugated fluorescein (diluted 1:200 in Amplification Diluent; Perkin Elmer) for 10 min and then washed for 30 min in TNT. Slides were subsequently incubated with the second primary antisera, from which point onwards the protocol for conventional indirect immunofluorescence was followed. Images were captured by using an Olympus FV1000 confocal laser scanning microscope (Olympus, Tokyo, Japan).
For consistency, Western blot and immunofluorescence investigations involving the pancreas were performed on samples prepared from the splenic region of the tissue. Although the number, size and composition of the islets of Langerhans has been reported to vary along the length of the pancreas (Elayat et al. 1995) , comparisons between the splenic and duodenal regions of the pancreas revealed no obvious variation in NUCB1 distribution or signal intensity (data not shown).
Results
NUCB1 expression and distribution in pancreas
The expression of NUCB1 mRNA in the mouse pancreas was explored by performing RT-PCR on samples prepared from whole pancreas (data not shown), in addition to isolated islets of Langerhans and the remaining "non-endocrine" tissue (including acinar cells, duct cells and blood vessels) from the pancreata of C57BL/6 mice. NUCB1 mRNA was detected in the pancreatic tissue in which its expression was limited to the endocrine islets; it was completely absent from the nonendocrine tissue (Fig. 1a) .
Full-length DNA sequencing of the NUCB1 gene extracted from isolated pancreatic islets was found to correspond to NUCB1 transcript variant 1 (National Centre for Biotechnology Information accession number NM_001163662), whereas no sequences were found to match transcript variant 2 (accession number NM_008749; n=17).
Western blotting of whole pancreas (Fig. 1b) revealed a band at approximately 63 kDa, corresponding to the expected size of the NUCB1 protein (Lavoie et al. 2002; Wendel et al. 1995) .
NUCB1 distribution in islets of Langerhans
Immunofluorescence staining performed on formalin-fixed sections of mouse pancreas revealed NUCB1 in the islets of Langerhans, whereas no signal above background levels was detected in the surrounding exocrine acinar cells or pancreatic ducts, with the exception of occasional fluorescence in blood vessels (n [animals]=8; Fig. 1c) . Incubation of adjacent sections with NUCB1 antiserum pre-absorbed with the antigenic peptide used for immunisation (corresponding to the Cterminal sequence: KVPEQPPELPQLDSQHL) greatly diminished NUCB1 immunoreactivity (IR) in the islets of Langerhans (Fig. 1d) , indicating that the signal detected by the NUCB1 antiserum corresponded to the NUCB1 protein.
NUCB1-IR was broadly and evenly distributed within the islets of Langerhans. In order specifically to identify the various islet cell types in which NUCB1 was located, double-staining immunofluorescence was performed by using antisera against glucagon (n=8), insulin (n=12), somatostatin (n=8), pancreatic polypeptide (n=8) and ghrelin (n=2). NUCB1 was detected in all cells immunoreactive for each of these hormones, indicating that NUCB1 was present in alpha, beta, gamma, delta and epsilon cells in the mouse pancreas. Meanwhile, NUCB1 was not detected in tissue regions outside of the apparent islet structures, further supporting the absence of NUCB1 in the exocrine tissue (Fig. 2) .
The subcellular distribution of NUCB1 in the mouse islet cells was investigated by double-staining for proteins specific for the following organelles (n=8 for each): the endoplasmic reticulum protein calnexin (David et al. 1993) , the Golgi apparatus protein giantin (Linstedt and Hauri 1993) and the mitochondrial protein translocase of the outer membrane 20 (TOM20; Ramage et al. 1993) . The co-distribution of NUCB1-IR with giantin-IR was extensive (Fig. 3a-c) , whereas NUCB1-IR was not spatially associated with either calnexin-IR (Fig. 3d-f ) or TOM20-IR (Fig. 3g-i) . Furthermore, NUCB1-IR was not observed within the DAPI-stained nuclear regions of islet cells. This suggests that NUCB1 is exclusively localised to the Golgi apparatus in pancreatic islet cells, at least under the conditions in which the tissue was prepared. The existence of NUCB2 in the pancreatic beta cells has previously been reported (Foo et al. 2010; Gonzalez et al. 2009; Stengel et al. 2009 ). Having revealed the concurrent presence of NUCB1 in these cells, we compared the subcellular distribution of both NUCB1 and NUCB2. NUCB2-IR was broadly dispersed throughout the cytoplasm and was largely distinct from NUCB1-IR (Fig. 3j-l) .
NUCB1 expression and distribution in other endocrine organs
In addition to the pancreas, several endocrine organs were explored for the presence of NUCB1 mRNA and protein. RT-PCR analysis was performed on samples from mouse pituitary, stomach, duodenum, jejunum, colon, adrenals, testes and ovaries. Bands corresponding to NUCB1 cDNA were detected in all these tissues (Fig. 4a) .
Western blotting performed on samples from the same tissue types (n=10 for all tissues except testes [n = 6] and ovaries [n = 4]) revealed a strong band at ∼63 kDa, corresponding to the expected size for NUCB1 (Wendel et al. 1995) , in all samples (Fig. 4b) except for the duodenum. Here, the absence of a band for actin (data not shown) suggested a general lack of detectable protein within the duodenal preparations, possibly because of the comparatively high endogenous proteolytic activity in this tissue (Borgström et al. 1957) . A second band was detected with the NUCB1 antiserum in all samples at ∼42 kDa, with a third band at ∼39 kDa, as also seen in the stomach and jejunum. In each of these tissues, none of these three bands was revealed on membranes treated with NUCB1 antiserum pre-incubated with the antigenic peptide (data not shown).
Although Western blot analysis showed the general presence of the protein in the tissues, we wished to identify the exact cell types in which it was located. With immunofluorescence staining, NUCB1-IR was observed throughout the gastrointestinal tract, albeit not in all cell types. In the stomach (Fig. 4c) , fluorescence signal was concentrated in the fundus region of the gastric glands, whereas the neck region and gastric pits displayed no NUCB1-IR. Identification of enteroendocrine cells through double-staining with the peptide hormone somatostatin demonstrated the presence of NUCB1 in these cells (Fig. 4c, inset) . Despite the absence of a 63-kDa band in the Western blot of the duodenal sample, immunofluorescence staining showed the existence of NUCB1-IR in the duodenum (Fig. 4d) . As with the jejunum (Fig. 4e) and colon (Fig. 4f) , NUCB1-IR was concentrated primarily in the duodenal enterocytes in which it was situated apically and adjacent to the cell nuclei (not shown). In contrast, the lamina propria displayed little fluorescent signal, although occasional cells deep within the villi were immunoreactive. Cells with stronger fluorescence were often observed deep in the intestinal glands and positive double-staining for somatostatin and ghrelin indicated that these, as in the stomach, were enteroendocrine cells (Fig. 4e, inset) . A lack of NUCB1-IR was also noted in the muscular wall of the intestines in which, again, only occasional cells displayed fluorescent signal.
High levels of NUCB1-IR were seen in both the thyroid and parathyroid glands (Fig. 4g) . This was especially true of the parathyroid in which NUCB1-IR was strong in the principal cells, whereas in the thyroid, immunostaining was concentrated in cells surrounding the follicles.
In the adrenal glands, NUCB1-IR was most apparent in cell profiles in the adrenal medulla and zona glomerulosa of the adrenal cortex, while being weaker (although not entirely absent) in the zona fasciculata and zona reticularis (Fig. 4h) . in the interstitial tissue, the site of the Leydig cells (Fig. 4i) . NUCB1-IR was observed in the follicular cells of the ovaries, with fluorescence being strongest in the cumulus oophorus and cells of the stratum granulosum bordering the antrum. The oocyte, theca interna, theca external and stroma were largely devoid of fluorescent signal (Fig. 4j) .
NUCB1-IR was observed in the anterior, intermediate and posterior lobes of the pituitary (n=8; Fig. 4k ). Further investigation by double-staining immunofluorescence revealed NUCB1-IR to be present in virtually all cells of the anterior lobe immunoreactive for adrenocorticotrophic hormone, growth hormone, thyroid-stimulating hormone, prolactin or follicle-stimulating hormone (Fig. 5) , indicating that NUCB1 existed in the corticotrophic, somatotrophic, thyrotrophic, lactotrophic and gonadotrophic cells.
In NUCB1-immunoreactive cells, the distribution of signal consistently appeared in a Golgi-like pattern (see Figs. 2 , 4c, e, 5 insets). Furthermore, all of the NUCB1-IR described above was absent from consecutive tissue sections incubated with antisera that had been pre-absorbed with the antigenic peptide (not shown). -c red) , the endoplasmic reticulum protein calnexin (d-f red) and the mitochondria protein translocase of the outer membrane 20 (TOM20; g-i red). Note overlapping distribution of immunoreactivity for NUCB1 and giantin but spatial segregation of immunoreactivity for NUCB1, calnexin and TOM20, indicating that NUCB1 is restricted to the Golgi apparatus. Cells displaying NUCB2 immunoreactivity (j-l red) also stained positively for NUCB1. Note, however, that whereas NUCB1 immunoreactivity is visible close to the cell nucleus, NUCB2 is widely dispersed throughout the cell cytoplasm. Nuclei are stained with DAPI (blue). Bars 5 µm
Discussion
To date, studies of NUCB1 have been predominantly limited to primary cell cultures and cell lines. No comprehensive mapping in intact tissue has been presented. Here, we have investigated the location of NUCB1 within endocrine tissues of the mouse, with particular focus on the pancreas. Our results reveal a broad, but discrete, expression pattern in all organs -but not all cell types -under investigation, i.e. the pancreas, pituitary, thyroid, parathyroid, stomach, duodenum, jejunum, colon, adrenals and gonads. In pancreatic islets, we demonstrate the presence of NUCB1 in the Golgi complex; a similar distribution has also been observed in other NUCB1-immunoreactive cells. Information in human gene expression databases, such as GeneCards (http://www.genecards.org/) demonstrates that NUCB1 is expressed in a wide variety of human tissues, including those investigated here in the mouse. Immunofluorescence staining and Western blot analysis was performed by using an antibody raised against the C-terminus of the mouse form of NUCB1 (Petersson et al. 2004 ). Pre-absorption of the antiserum with the antigenic peptide resulted in an absence of signal both in tissue sections and on the Western blot membranes, indicating that the signal obtained by using the antiserum was specific for the NUCB1 protein. These controls and the similarities in tissue distribution observed with immunofluorescence, Western blot and RT-PCR support the conclusion that the mRNA and protein signals that we describe indeed correspond to NUCB1.
NUCB1 has previously been referred to as a ubiquitously expressed protein (Kanuru et al. 2013; Kapoor et al. 2010; Lavoie et al. 2002; Leclerc et al. 2008 ) with a possible housekeeping role (Miura et al. 1996) . We show here that, whereas several prominent populations express NUCB1 at high levels, the protein is notably absent from other subgroups of cells. For example, in the pancreas, the islets of Langerhans have been identified by RT-PCR, Western blot and immunofluorescence as expressing NUCB1, whereas the acinar cells responsible for secreting digestive enzymes from the exocrine pancreas are devoid of NUCB1 mRNA and IR. In all other tissues examined, NUCB1-IR is also confined to specific groups of cells. Within the islets, NUCB1 can be seen in all five hormone-secreting cell types. Similarly, all endocrine subpopulations of the anterior pituitary lobe contain the protein (see also Lin et al. 1998) . Our data thus suggest that NUCB1 is particularly prevalent in, albeit not ubiquitous to, endocrine cell types (noting the absence of the protein in, for example, testosterone-producing Leydig cells; present findings). Notably, in this context, the demarcation between an endocrine and a non-endocrine cell type is no longer distinct, as a growing range of cell types not classically considered as endocrine are being shown to secrete hormones, e.g. adipocytes and osteocytes (Dallas et al. 2013; Kershaw and Flier 2004) . Intriguingly, we have recently also found the generalised expression of NUCB1 in central neurons, which also release messenger molecules onto other cells (S. Tulke et al., unpublished) .
Within individual cells, NUCB1-IR has been seen in a distribution consistent with the Golgi compartment and, in islet cells, it is colocalised with the Golgi membrane protein, giantin (Linstedt and Hauri 1993) . These findings are in agreement with earlier reports identifying NUCB1 in the Golgi compartment in mammalian and arthropod cell lines and rat pituitary (Kawano et al. 2000; Lavoie et al. 2002; Lin et al. 1998 ). Our observations in the seminiferous tubules provide further support for a specific NUCB1-Golgi association. Here, the signal for NUCB1-IR is strongest around the perimeter of the tubules, gradually becoming weaker towards the central lumen, the direction in which spermatozoan development takes place. As early stage spermatogonia and spermatocytes mature into spermatozoa, the Golgi apparatus diminishes, giving rise to the acrosome, before being separated off into the residual body (Breucker et al. 1985) . Thus, in testis, the gradual dissolution of the Golgi is paralleled by a successively weakened NUCB1-immunoreactive signal.
The functional role of NUCB1 within cells remains obscure. Evidence has been presented for an interaction between the protein and several potential partners, including G-protein subunits of the α subtype (Gα; Kapoor et al. 2010; Lin et al. 2009 Lin et al. , 2000 Mochizuki et al. 1995) , β-amyloid precursor protein (Lin et al. 2007 ) and cyclooxygenase 2 (Leclerc et al. 2008 ). The Ca 2+ -binding capacity (Kanuru et al. 2009; Lin et al. 1998; Miura et al. 1994; Wendel et al. 1995) , as reflected in the presence of dual EF-hand motifs (de Alba and Tjandra 2004; Miura et al. 1994 ), of NUCB1 is particularly noteworthy. Cellular calcium uptake increases when NUCB1 is overexpressed in cultured cells (Lin et al. 1999) . The Golgi compartment forms a major intracellular Ca 2+ store (Chandra et al. 1991; Pezzati et al. 1997; Pinton et al. 1998 ) and NUCB1 has been proposed to act in concert with sarcoplasmic/ endoplasmic reticulum calcium ATPase (SERCA) pumps to maintain Golgi Ca 2+ pools (Lin et al. 1998 ). Other than a report that NUCB1 might interact with Gα i1 in a Ca 2+ -sensitive manner (Kapoor et al. 2010) , the downstream effects of NUCB1-Ca 2+ binding are not presently known. Intracellular Ca 2+ homeostasis is vital in all cell types but particularly so in cells in which extrinsic stimuli for hormone secretion are often translated into spatially and temporally constricted rises in this divalent cation. In beta cells in which this phenomenon has been studied in detail, Ca 2+ influx via voltage-gated calcium channels (induced by the depolarisation occurring after an increase in glucose metabolism that leads to increased intracellular ATP and subsequent closure of ATPdependent K + channels) is the trigger for insulin exocytosis (Henquin and Meissner 1984; Mears 2004; Satin 2000; Yang and Berggren 2006) . Precise handling of intracellular Ca 2+ is crucial for the correct functioning of this process. Expression of the CaBPs calmodulin, calretinin and calbindin has been documented in the rat pancreas (Bazwinsky-Wutschke et al. 2010) . Important roles have been described for calmodulin and calbindin in islet stimulus-secretion coupling (Krausz et al. 1980; Sooy et al. 1999) . Recent evidence also suggests that the CaBP secretagogin, which is strongly expressed in pancreatic islets, might play an important role in islet cell function (Wagner et al. 2000) . Despite the addition of NUCB1 to this repertoire of CaBPs found in pancreatic islets and other endocrine cells, whether this protein also contributes to the control or mediation of changes in intracellular Ca 2+ remains to be investigated.
Despite their similar structures, no consistent correlation seems to exist between the expression of NUCB1 and NUCB2 in cells, either in a co-existent or in a mutually exclusive manner. NUCB1-IR has been observed in all cell types comprising the islets of Langerhans, whereas pancreatic NUCB2 is located exclusively in the beta cells (Foo et al. 2010; Gonzalez et al. 2009; Stengel et al. 2009 ). However, here, the distribution of the two nucleobindin proteins remains distinct, with NUCB1 retaining its apparent association with the Golgi apparatus, contrasting with the wide dispersal of NUCB2 throughout the cytoplasm. In addition, NUCB2 expression in the testis has been identified in the Leydig cells (Garcia-Galiano et al. 2012) , whereas NUCB1 is lacking in the interstitial tissue, being instead present only inside the seminiferous tubules.
The widespread distribution of NUCB1 in endocrine cells demonstrated here, coupled with its Golgi-apparatusassociated subcellular distribution, suggests that this protein plays a role in the operation of secretory cells. The potential of NUCB1 to act as a signalling molecule is supported by its range of putative interaction partners as previously described, including DNA (Miura et al. 1992) , calcium (Kanuru et al. 2009; Miura et al. 1994; Wendel et al. 1995) and Gα subunits (Kapoor et al. 2010; Lin et al. 1998 Lin et al. , 2000 Lin et al. , 2009 Mochizuki et al. 1995) . Future studies are warranted to identify the function of NUCB1 and to determine whether this includes a role in hormone secretion.
